An investment analyst forecasts significant layoffs at Novo Nordisk. Up to five thousand staff reductions are predicted within two years. This prediction follows a decline in future earnings expectations. The company needs to address its cost structure. This view comes from an analyst and economist.
https://medwatch.com/News/Pharma___Biotech/article19163186.ece